DCF — VIRGINIA MASON MEDICAL CENTER
Enterprise Value: $-980.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-980.8M
Enterprise Value
$-328.1M
PV of Cash Flows
$-652.7M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-51.4M | -5.0% | $-99.8M | $-90.7M |
| Year 2 | $1.2B | $-41.2M | -4.0% | $-91.0M | $-75.2M |
| Year 3 | $1.2B | $-30.3M | -3.0% | $-81.6M | $-61.3M |
| Year 4 | $1.2B | $-25.0M | -2.0% | $-77.8M | $-53.1M |
| Year 5 | $1.3B | $-22.5M | -2.0% | $-76.9M | $-47.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-980.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000045086273
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5